IGC PHARMA, INC. Adjustments to Additional Paid in Capital, Other
IGC PHARMA, INC. (IGC) reported Adjustments to Additional Paid in Capital, Other of $1.15 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2026-08-14
- IGC PHARMA, INC. adjustments to additional paid in capital, other for the quarter ending 2026-06-30 was $1.15M, a 8776.92% increase year-over-year.
- IGC PHARMA, INC. adjustments to additional paid in capital, other for the quarter ending 2026-03-31 was -$264.00K.
- IGC PHARMA, INC. adjustments to additional paid in capital, other for the quarter ending 2025-06-30 was $13.00K.
- IGC PHARMA, INC. adjustments to additional paid in capital, other for the quarter ending 2025-03-31 was $0.00.
- IGC PHARMA, INC. adjustments to additional paid in capital, other for fiscal 2025 was $200.00K.
- IGC PHARMA, INC. adjustments to additional paid in capital, other for fiscal 2024 was $0.00.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month | Adjustments to Additional Paid in Capital, Other 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $1.15M 10-Q · filed 2026-08-14 | $890.00K 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | -$264.00K 10-Q · filed 2026-05-15 | ||||
| 2025-12-31 | $234.00K 10-KT · filed 2026-03-18 | ||||
| 2025-06-30 | $13.00K 10-Q · filed 2026-08-14 | $13.00K 10-Q · filed 2026-08-14 | $13.00K derived: sum of 3 quarters · filed 2026-08-14 | $440.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 | $0.00 derived: sum of 2 quarters · filed 2026-05-15 | $427.00K derived: sum of 3 quarters · filed 2026-05-15 | $200.00K 10-KT · filed 2026-03-18 | |
| 2024-12-31 | $0.00 10-Q · filed 2025-02-14 | $427.00K derived: sum of 2 quarters · filed 2025-11-14 | $200.00K 10-Q · filed 2025-02-14 | $427.00K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-09-30 | $427.00K 10-Q · filed 2025-11-14 | $427.00K 10-Q · filed 2025-11-14 | $427.00K derived: sum of 3 quarters · filed 2025-11-14 | $427.00K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-14 | $0.00 derived: sum of 2 quarters · filed 2025-08-14 | $0.00 derived: sum of 3 quarters · filed 2025-08-14 | $0.00 derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-27 | $0.00 derived: sum of 2 quarters · filed 2025-06-27 | $0.00 derived: sum of 3 quarters · filed 2025-06-27 | $0.00 10-K · filed 2025-06-27 | $500.00K 10-K · filed 2024-06-24 |
| 2023-12-31 | $0.00 10-Q · filed 2025-02-14 | $0.00 derived: sum of 2 quarters · filed 2025-02-14 | $0.00 10-Q · filed 2025-02-14 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |